Does SITAGLIPTIN Cause Nephrolithiasis? 153 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 153 reports of Nephrolithiasis have been filed in association with SITAGLIPTIN (JANUVIA). This represents 0.8% of all adverse event reports for SITAGLIPTIN.
153
Reports of Nephrolithiasis with SITAGLIPTIN
0.8%
of all SITAGLIPTIN reports
85
Deaths
121
Hospitalizations
How Dangerous Is Nephrolithiasis From SITAGLIPTIN?
Of the 153 reports, 85 (55.6%) resulted in death, 121 (79.1%) required hospitalization, and 32 (20.9%) were considered life-threatening.
Is Nephrolithiasis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SITAGLIPTIN. However, 153 reports have been filed with the FAERS database.
What Other Side Effects Does SITAGLIPTIN Cause?
Blood glucose increased (1,427)
Pancreatic carcinoma (1,142)
Product dose omission issue (1,125)
Drug ineffective (1,057)
No adverse event (994)
Nausea (936)
Pancreatitis (922)
Diabetes mellitus inadequate control (744)
Diarrhoea (712)
Hypoglycaemia (674)
What Other Drugs Cause Nephrolithiasis?
ADALIMUMAB (2,416)
ETANERCEPT (1,292)
INFLIXIMAB (981)
METHOTREXATE (979)
ABATACEPT (788)
TOPIRAMATE (768)
CERTOLIZUMAB PEGOL (735)
RITUXIMAB (709)
TOFACITINIB (699)
SODIUM OXYBATE (698)
Which SITAGLIPTIN Alternatives Have Lower Nephrolithiasis Risk?
SITAGLIPTIN vs SOAP
SITAGLIPTIN vs SODIUM
SITAGLIPTIN vs SODIUM BICARBONATE
SITAGLIPTIN vs SODIUM BICARBONATE\SODIUM
SITAGLIPTIN vs SODIUM BORATE